| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 189.78B | 195.61B | 218.94B | 263.31B | 184.63B |
| Gross Profit | 21.81B | 55.53B | 62.37B | 81.21B | 52.01B |
| EBITDA | 35.67B | 42.28B | 50.78B | 59.04B | 42.07B |
| Net Income | 13.66B | 15.76B | 21.38B | 20.53B | 16.03B |
Balance Sheet | |||||
| Total Assets | 291.09B | 285.49B | 283.65B | 303.86B | 293.46B |
| Cash, Cash Equivalents and Short-Term Investments | 29.54B | 30.55B | 33.43B | 41.77B | 33.66B |
| Total Debt | 61.04B | 51.24B | 47.87B | 61.25B | 64.55B |
| Total Liabilities | 173.55B | 165.23B | 164.20B | 189.29B | 178.46B |
| Stockholders Equity | 114.90B | 117.86B | 116.75B | 111.72B | 111.74B |
Cash Flow | |||||
| Free Cash Flow | 10.81B | 15.95B | 22.96B | 31.68B | 18.07B |
| Operating Cash Flow | 28.46B | 30.85B | 40.68B | 47.37B | 30.41B |
| Investing Cash Flow | -18.57B | -17.33B | -16.45B | -15.12B | -13.66B |
| Financing Cash Flow | -10.64B | -14.43B | -29.73B | -19.27B | -25.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | €7.36B | 14.03 | 77.67% | 4.99% | 35.00% | 24.05% | |
76 Outperform | €2.03B | 3.06 | 34.90% | 6.70% | -14.28% | -9.30% | |
73 Outperform | €162.56B | 10.74 | 12.75% | 5.87% | -11.20% | -13.26% | |
69 Neutral | €6.02B | 15.94 | ― | 2.64% | 17.19% | 11.76% | |
67 Neutral | €981.00M | 11.20 | 4.13% | 47.20% | -8.54% | 47.48% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |